ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 51 filers reported holding ORCHARD THERAPEUTICS PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $356,000 | -17.0% | 712,001 | -2.9% | 0.00% | – |
| Q2 2022 | $429,000 | -19.7% | 733,547 | -2.2% | 0.00% | – |
| Q1 2022 | $534,000 | -35.4% | 749,990 | +19.9% | 0.00% | – |
| Q4 2021 | $826,000 | -45.0% | 625,512 | -4.2% | 0.00% | – |
| Q3 2021 | $1,502,000 | -49.4% | 652,833 | -3.4% | 0.00% | – |
| Q2 2021 | $2,966,000 | -22.5% | 675,716 | +28.1% | 0.00% | – |
| Q1 2021 | $3,829,000 | +64.8% | 527,374 | -2.0% | 0.00% | – |
| Q4 2020 | $2,324,000 | -19.6% | 537,971 | -23.5% | 0.00% | – |
| Q3 2020 | $2,891,000 | -32.1% | 703,497 | -0.9% | 0.00% | – |
| Q2 2020 | $4,259,000 | +56.8% | 709,895 | +96.8% | 0.00% | – |
| Q1 2020 | $2,716,000 | -47.7% | 360,752 | -4.5% | 0.00% | – |
| Q4 2019 | $5,197,000 | +606.1% | 377,940 | +618.6% | 0.00% | – |
| Q2 2019 | $736,000 | – | 52,592 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 5,307,751 | $3,101,000 | 1.18% |
| TANG CAPITAL MANAGEMENT LLC | 2,000,000 | $1,168,000 | 0.18% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $4,060,000 | 0.08% |
| Artal Group S.A. | 1,803,858 | $1,054,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 616,402 | $360,000 | 0.05% |
| RA Capital Management | 3,040,885 | $1,776,000 | 0.05% |
| Forefront Analytics, LLC | 92,641 | $58,000 | 0.03% |
| Temasek Holdings (Private) Ltd | 4,319,049 | $2,523,188 | 0.01% |
| FEDERATED HERMES, INC. | 8,309,859 | $4,853,000 | 0.01% |
| Cormorant Asset Management, LP | 256,649 | $150,000 | 0.01% |